EMEA-000583-PIP01-09-M08
Key facts
Invented name |
Victrelis
|
Active substance |
Boceprevir
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0156/2020
|
PIP number |
EMEA-000583-PIP01-09-M08
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of chronic hepatitis C
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Merck Sharp & Dohme (Europe) Inc.
Tel.: +33180464738 |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|